Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
104 studies found for:    aspirin | United States, New York | Studies with Male Participants
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Conditions: Heart Disease;   Stroke;   Ischemic Heart Disease;   Myocardial Infarction
Interventions: Drug: aspirin;   Drug: Warfarin
2 Recruiting Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Condition: Cancer Patients First-ever Acute Ischemic Stroke
Interventions: Drug: Enoxaparin;   Drug: Aspirin
3 Completed Secondary Prevention of Small Subcortical Strokes Trial
Conditions: Cerebrovascular Accident;   Hypertension
Interventions: Drug: aspirin;   Drug: clopidogrel;   Other: Target of Blood Pressure;   Other: placebo
4 Active, not recruiting A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
Condition: Moderate Risk of CVD
Interventions: Drug: Aspirin (Acetylsalicylic acid, BAYE4465);   Drug: Placebo
5 Recruiting [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Conditions: Acute Ischaemic Stroke;   Transient Ischaemic Attack.
Interventions: Drug: ticagrelor;   Drug: Acetylsalicylic acid (ASA)
6 Active, not recruiting Aspirin in Reducing Events in the Elderly
Conditions: Functional Disability;   Dementia;   Heart Disease;   Stroke;   Cancer;   Bleeding;   Depression
Interventions: Drug: 100 mg enteric-coated aspirin;   Drug: Placebo
7 Completed Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
Condition: Acute Migraine
Interventions: Drug: Acetaminophen 250 mg and Aspirin 250 mg;   Drug: Placebo
8 Completed Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Condition: Colorectal Cancer
Intervention: Drug: acetylsalicylic acid
9 Enrolling by invitation ASPREE Cancer Endpoints Study
Condition: Cancer
Interventions: Drug: Aspirin;   Drug: Placebo
10 Recruiting Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Condition: Prevention & Control
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
11 Recruiting A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
12 Terminated Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
13 Recruiting A Study of the Efficacy and Safety of Activase (Alteplase) in Patients With Mild Stroke (PRISMS)
Condition: Brain Ischemia
Interventions: Drug: alteplase [Activase];   Drug: alteplase placebo;   Drug: aspirin;   Drug: aspirin placebo
14 Active, not recruiting The Dual Antiplatelet Therapy Study (DAPT Study)
Condition: Coronary Artery Disease
Interventions: Drug: Placebo & Aspirin;   Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin
15 Completed Warfarin and Antiplatelet Therapy in Chronic Heart Failure
Condition: Heart Failure
Interventions: Drug: Warfarin titrated to an INR of 2.5-3.0;   Drug: Aspirin;   Drug: Clopidogrel 75
16 Completed
Has Results
Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine
Condition: Pain, Migraine
Interventions: Drug: Aspirin, acetaminophen and caffeine;   Drug: Sumatriptan;   Drug: Placebo
17 Completed XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Conditions: Chronic Total Occlusion of Coronary Artery;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Intervention: Drug: DAPT
18 Recruiting Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Condition: Peripheral Artery Disease (PAD)
Interventions: Drug: Ticagrelor;   Drug: Comparator
19 Active, not recruiting
Has Results
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Acetylsalicylic acid
20 Completed
Has Results
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel;   Drug: Prasugrel;   Drug: Commercially-available Aspirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years